506 related articles for article (PubMed ID: 27343361)
1. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
Ferrer CM; Sodi VL; Reginato MJ
J Mol Biol; 2016 Aug; 428(16):3282-3294. PubMed ID: 27343361
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
3. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
4. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
Le Minh G; Reginato MJ
Adv Cancer Res; 2023; 157():195-228. PubMed ID: 36725109
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA; Chen W; Bond MR
J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
[TBL] [Abstract][Full Text] [Related]
6. On a sugar high: Role of O-GlcNAcylation in cancer.
Le Minh G; Esquea EM; Young RG; Huang J; Reginato MJ
J Biol Chem; 2023 Nov; 299(11):105344. PubMed ID: 37838167
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
Itano N; Iwamoto S
Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
[TBL] [Abstract][Full Text] [Related]
8. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
9. Cancer metabolism: cross talk between signaling and O-GlcNAcylation.
Ferrer CM; Reginato MJ
Methods Mol Biol; 2014; 1176():73-88. PubMed ID: 25030920
[TBL] [Abstract][Full Text] [Related]
10. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
Akella NM; Ciraku L; Reginato MJ
BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
[TBL] [Abstract][Full Text] [Related]
11. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
12. [O-GlcNAc glycosylation and regulation of cell signaling].
Issad T
Med Sci (Paris); 2010; 26(8-9):753-9. PubMed ID: 20819714
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc in cancer biology.
Ma Z; Vosseller K
Amino Acids; 2013 Oct; 45(4):719-33. PubMed ID: 23836420
[TBL] [Abstract][Full Text] [Related]
14. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
Ma Z; Vosseller K
J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
[TBL] [Abstract][Full Text] [Related]
15. Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals.
Liu X; Cai YD; Chiu JC
J Biol Chem; 2024 Feb; 300(2):105616. PubMed ID: 38159854
[TBL] [Abstract][Full Text] [Related]
16. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
18. Metabolic control of hyaluronan synthases.
Vigetti D; Viola M; Karousou E; De Luca G; Passi A
Matrix Biol; 2014 Apr; 35():8-13. PubMed ID: 24134926
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.
Taparra K; Wang H; Malek R; Lafargue A; Barbhuiya MA; Wang X; Simons BW; Ballew M; Nugent K; Groves J; Williams RD; Shiraishi T; Verdone J; Yildirir G; Henry R; Zhang B; Wong J; Wang KK; Nelkin BD; Pienta KJ; Felsher D; Zachara NE; Tran PT
J Clin Invest; 2018 Nov; 128(11):4924-4937. PubMed ID: 30130254
[TBL] [Abstract][Full Text] [Related]
20. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
